XML 28 R20.htm IDEA: XBRL DOCUMENT v3.24.3
Shareholders' Equity and Share Based Compensation
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Shareholders' Equity and Share Based Compensation

12. SHAREHOLDERS’ EQUITY AND SHARE-BASED COMPENSATION

Share-based compensation expense was $875 and $3,476 for the three and nine months ended September 30, 2024, respectively, and $747 and $3,135 for the three and nine months ended September 30, 2023, respectively.

Stock option activity for the nine months ended September 30, 2024 was as follows:

 

 

Number of
Options

 

 

Weighted
Average
Exercise Price

 

 

Weighted
Average
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

Outstanding at January 1, 2024

 

 

6,946,576

 

 

$

3.50

 

 

 

7.54

 

 

$

83

 

Granted

 

 

170,000

 

 

$

0.95

 

 

 

6.21

 

 

$

5

 

Forfeited/expired

 

 

(424,167

)

 

$

3.43

 

 

 

 

 

 

 

Outstanding at September 30, 2024

 

 

6,692,409

 

 

$

3.43

 

 

 

7.09

 

 

$

294

 

Exercisable at September 30, 2024

 

 

3,600,055

 

 

$

5.24

 

 

 

5.97

 

 

$

57

 

Restricted shares activity for the nine months ended September 30, 2024 was as follows:

 

 

Number of
Restricted Stock Grants

 

 

Weighted Average Grant Date Fair Value

 

Outstanding at January 1, 2024

 

 

 

 

$

-

 

Granted

 

 

1,785,144

 

 

$

1.20

 

Vested and Issued

 

 

(1,479,024

)

 

$

1.25

 

Outstanding at September 30, 2024

 

 

306,120

 

 

$

0.98

 

Exercisable at September 30, 2024

 

 

 

 

$

-

 

On September 3, 2024, the Company granted 600,000 shares to a director of the Company.